# Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE

> **NCT03731910** · NA · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 35 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** MRI

## Key facts

- **NCT ID:** NCT03731910
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-11
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2021-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03731910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03731910, "Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03731910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*